Big Pharma Slashes Spending On Doctors' Sales Talks
3/4/2014 7:44:12 AM
Some of the nation's largest pharmaceutical companies have dramatically reduced payments to health professionals for promotional speeches amid heightened public scrutiny of such spending, a ProPublica analysis shows. Eli Lilly & Co.'s payments to speakers dropped by 55 percent, from $47.9 million in 2011 to $21.6 million in 2012. Pfizer's speaking payments fell 62 percent over the same period, from nearly $22 million to $8.3 million.
Help employers find you! Check out all the jobs and post your resume.
comments powered by